# Prexa Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prexa-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Boston, US
- Website: www.prexainc.com
- Total disclosed funding: $6.4M
- Latest round: Series B (Apr 29, 2011)
- Investors on record: 2

## About

Prexa, founded in 2006, is developing oral small molecule monoamine reuptake inhibitors that act most potently at the dopamine transporter. By safely enhancing dopamine activity and, to a lesser extent norepinephrine activity, Prexa intends to improve upon current treatments for ADHD, depression and Parkinson’s disease.

## Funding rounds

- Series B, Apr 29, 2011, $3.3M — Advent International, Shire
- Series A, Jun 1, 2006, $3.1M — Advent International

## Investors

- Advent International (https://capitalatlas.ai/funds/advent-international) — Series A, Series B
- Shire — Series B